Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care
Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care
Not yet recruiting · NCT07542990 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care | Confusion, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Not yet recruiting | Phase 3 | 2026-09-28 | NCT07542990 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU d'Angers | Angers | France | 25 |
| CHU de CAEN | Caen | France | 28 |
| CHU de Lille | Lille | France | 1 |
| CHU de Marseille | Marseille | France | 1 |
| Chu de Nantes | Nantes | France | 72 |
| CHU de Strasbourg | Strasbourg | France | 1 |
| Chu De Tours | Tours | France | 6 |